ZYBT

Zhengye Biotechnology Holding Limited Ordinary Shares

9 hedge funds and large institutions have $2.51M invested in Zhengye Biotechnology Holding Limited Ordinary Shares in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
+6
Holders Change %
+200%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
3
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Jane Street
1
Jane Street
New York
$1.16M +$1.16M +193,982 New
UBS Group
2
UBS Group
Switzerland
$922K +$915K +153,223 +11,887%
Invesco
3
Invesco
Georgia
$220K +$220K +36,839 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$174K +$174K +29,068 New
TRCT
5
Tower Research Capital (TRC)
New York
$19.9K +$19.9K +3,335 +333,500%
Morgan Stanley
6
Morgan Stanley
New York
$14.5K +$14.3K +2,390 +5,196%
BNP Paribas Financial Markets
7
BNP Paribas Financial Markets
France
$1.56K +$1.56K +262 New
Bank of America
8
Bank of America
North Carolina
$436 +$436 +73 New